{"disease":{"id":"avian-influenza","name":"avian influenza"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02839330","title":"A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3196,"lead_sponsor_name":"Seqirus","has_results":true},{"nct_id":"NCT02612909","title":"A Safety and Immunogenicity Study of IVACFLU-A/H5N1","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":930,"lead_sponsor_name":"Institute of Vaccines and Medical Biologicals, Vietnam","has_results":true},{"nct_id":"NCT03312231","title":"Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06842173","title":"Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT03014310","title":"H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":388,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03682120","title":"Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07275060","title":"Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":312,"lead_sponsor_name":"Canadian Immunization Research Network","has_results":false},{"nct_id":"NCT03738241","title":"2017 A/H7N9 IIV Revaccination","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT02624219","title":"H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03589807","title":"2013/2017 H7N9 Prime-Boost Interval","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03318315","title":"Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07240558","title":"Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT07019883","title":"A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02251288","title":"A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03472976","title":"H5N1 With or Without Topical Aldara in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02921997","title":"H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}